A Multicenter, Randomized, Double Blind, Parallel Design Trial to Evaluate the Blood Pressure Lowering Efficacy Comparing Moderate Versus Aggressive Treatment Regimen of Valsartan + Amlodipine in Patients Uncontrolled on ARB Monotherapy.

Trial Profile

A Multicenter, Randomized, Double Blind, Parallel Design Trial to Evaluate the Blood Pressure Lowering Efficacy Comparing Moderate Versus Aggressive Treatment Regimen of Valsartan + Amlodipine in Patients Uncontrolled on ARB Monotherapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2011

At a glance

  • Drugs Amlodipine/valsartan (Primary) ; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms EXTRA
  • Sponsors Novartis
  • Most Recent Events

    • 21 Jun 2010 Results have been presented at the 20th European Meeting on Hypertension.
    • 18 Jun 2010 Results were presented at the 20th European Meeting on Hypertension.
    • 01 May 2010 Results were presented at the 25th Annual Scientific Meeting of the American Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top